EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure

Amina A Alkhalaf iD, Rishi J Desai, Julie C Lauffenburger

Pharmacoepidemiology and Drug Safety · 2025-04 · 34 (4)

DOI: 10.1002/pds.70130 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 25.03.2025. Verfasst von Amina A Alkhalaf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Furosemide, Heart Failure, Torsemide, Sodium Potassium Chloride Symporter Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Evidence on the real‐world comparative effectiveness and safety of commonly used loop diuretics for heart failure is mixed, particularly among older adults who are at a higher risk of adverse outcomes. Thus, we aimed to compare the outcomes and safety profiles of torsemide and furosemide.

Methods

We conducted a new user, active comparator retrospective cohort study comparing torsemide to furosemide in Medicare fee‐for‐service beneficiaries with heart failure in claims data (2008–2020). Effectiveness outcomes were a composite of heart failure hospitalization or death and urgent outpatient visits requiring intravenous diuretics; safety outcomes included acute kidney injury, hypovolemia, and hypokalemia. We used 1:4 propensity score (PS) matching to adjust for confounding. We calculated PS‐matched hazard ratios using Cox proportional hazard models.

Results

Across 328 640 matched beneficiaries, compared with furosemide, torsemide was associated with a similar, though statistically significantly lower, risk of the composite effectiveness outcome (hazard ratio [HR] = 0.97, 95% CI:0.95,0.99; incidence rate difference (IRD) = −3.79, 95% CI:‐9.38,1.81 events per 1000 person‐years) and lower risk for urgent visits with intravenous loop diuretics (HR = 0.88, 95% CI:0.84,0.92; IRD = −7.03, 95% CI:‐9.79,−4.26 events per 1000 person‐years). Torsemide was also associated with an increased risk of acute kidney injury (HR = 1.12, 95% CI:1.10,1.15; IRD = 36.89, 95% CI:31.51,42.64 events per 1000 person‐years) with no observed difference in hypokalemia (HR = 1.02, 95% CI:0.91,1.14; IRD = 0.46, 95% CI:−0.51,1.42 events per 1000 person‐years) and hypovolemia (HR = 1.03, 95% CI:0.98,1.09; IRD = 2.36, 95% CI:0.15,4.56 events per 1000 person‐years).

Conclusions

Compared with furosemide, initiation of torsemide was associated with a slightly lower risk of a composite of all‐cause mortality or heart failure hospitalization and urgent visits with intravenous diuretics, but a slightly higher risk of acute kidney injury. In older adults, clinicians must balance torsemide's potential benefits with the acute kidney injury risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurosemideHeart FailureTorsemideSodium Potassium Chloride Symporter InhibitorsHumansMaleFemaleAgedRetrospective StudiesAged, 80 and overUnited StatesMedicareHospitalizationPropensity ScoreDiureticsTreatment OutcomeAcute Kidney Injury

Stichwörter der Autor:innen

comparative effectivenesscomparative safetyfurosemideheart failureloop diureticstorsemide

Substanzen

FurosemideTorsemideSodium Potassium Chloride Symporter InhibitorsDiuretics

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Pharmacy Practice, College of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Amina A Alkhalaf

Zitieren

APA

Alkhalaf, A. A., Desai, R. J., & Lauffenburger, J. C. (2025). Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure. Pharmacoepidemiology and Drug Safety, 34(4). https://doi.org/10.1002/pds.70130

Vancouver

Alkhalaf AA, Desai RJ, Lauffenburger JC. Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure. Pharmacoepidemiology and Drug Safety. 2025;34(4). doi:10.1002/pds.70130

BibTeX
@article{Alkhalaf2025,
  author = {Alkhalaf, Amina A and Desai, Rishi J and Lauffenburger, Julie C},
  title = {Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  volume = {34},
  number = {4},
  doi = {10.1002/pds.70130}
}
Kostenlos starten →